Soft tissue tumor case studies
Soft tissue tumor case studies is a research topic within Rheumatology. Science Explorer counts 22k research works in it since 1950. 5.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the clinicopathologic characteristics, genetic mutations, and treatment strategies for fibrous tumors such as Solitary Fibrous Tumors and Desmoid Tumors. It discusses the identification of recurrent gene fusions, the distinction from histologic mimics, risk assessment models, and the efficacy of various treatments including surgery, radiation therapy, and targeted therapies.
- Solitary Fibrous Tumor
- Desmoid Tumor
- NAB2-STAT6 gene fusions
- Surgery
- Radiation Therapy
- CTNNB1 mutations
- Aggressive Fibromatosis
- Imatinib treatment
- PDGFRB mutations
- Prognostic Factors
- Research works
- 22k fractional, since 1950
- In the world top 10%
- 1.2k per year above
- Top-10% rate
- 5.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +8% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Soft tissue tumor case studies research?
By volume, the United States and India publish the most (617 and 401 works in 2022–2025).
By volume, 2022–2025
- 1 United States 617 works
- 2 India 401 works
- 3 China 336 works
- 4 Japan 221 works
- 5 Brazil 101 works
- 6 Spain 99 works
- 7 Germany 93 works
- 8 Italy 90 works
- 9 Türkiye 83 works
- 10 United Kingdom 80 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Soft tissue tumor case studies research?
By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Soft tissue tumor case studies research, followed by Mohammed V University and Mohamed I University.
By volume, 2022–2025
- 1 All India Institute of Medical Sciences India 25 works
- 2 Mohammed V University Morocco 14 works
- 3 Mohamed I University Morocco 10 works
- 4 Icahn School of Medicine at Mount Sinai United States 9 works
- 5 Institute of Medical Sciences India 9 works
- 6 Sichuan University China 9 works
- 7 Harvard University United States 9 works
- 8 Mayo Clinic in Arizona United States 9 works
- 9 The University of Texas MD Anderson Cancer Center United States 9 works
- 10 Post Graduate Institute of Medical Education and Research India 8 works
Who are the leading researchers in Soft tissue tumor case studies?
The most-cited researchers publishing on Soft tissue tumor case studies include David N. Louis and Alexander J. Lazar.
- 1 David N. Louis 2.7k citations
- 2 Alexander J. Lazar 2.3k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Soft tissue tumor case studies research done?
The largest centres of Soft tissue tumor case studies research in 2022–2025 are New Delhi (India), Tokyo (Japan), Beijing (China) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Rabat.
Largest cities, 2022–2025
Where it is the local speciality
- RabatMA · 22.6 works12×
Location quotient: how much more of its research is in Soft tissue tumor case studies than the world average.
Where is the best place to study Soft tissue tumor case studies?
Among universities, judged by research, All India Institute of Medical Sciences, Mohammed V University and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | All India Institute of Medical Sciences India | 54.0 | 0.9% | 13.9× | 25 | +22.4% |
| 2 | Mohammed V University Morocco | 54.0 | 0.0% | 12.2× | 14 | +116.5% |
| 3 | Harvard University United States | 45.7 | 20.1% | 2.4× | 9 | -21.2% |
| 4 | Mohamed I University Morocco | 39.9 | 0.0% | 21.6× | 10 | — |
| 5 | Institute of Medical Sciences India | 38.8 | 0.0% | 10.0× | 9 | +51.2% |
| 6 | Icahn School of Medicine at Mount Sinai United States | 38.6 | 6.1% | 6.7× | 10 | +25.1% |
| 7 | Post Graduate Institute of Medical Education and Research India | 37.9 | 0.0% | 8.7× | 8 | +121.7% |
| 8 | Sağlık Bilimleri Üniversitesi Türkiye | 25.6 | 2.1% | 4.9× | 8 | — |
| 9 | Datta Meghe Institute of Higher Education and Research India | 25.2 | 0.0% | 12.2× | 8 | -87.0% |
| 10 | Sichuan University China | 23.6 | 11.2% | 1.8× | 9 | -24.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Soft tissue tumor case studies research growing?
Output in 2018–2022 was 8% higher than in 2013–2017, peaking in 2020. The fastest-growing topics are Soft tissue tumor case studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.